These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Thrombocytopenia in HIV-infected drug users in the HAART era. Burbano X, Miguez MJ, Lecusay R, Rodriguez A, Ruiz P, Morales G, Castillo G, Baum M, Shor-Posner G. Platelets; 2001 Dec; 12(8):456-61. PubMed ID: 11798394 [Abstract] [Full Text] [Related]
5. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia. Papagianni A, Economou M, Tragiannidis A, Karatza E, Tsatra I, Gombakis N, Athanassiadou-Piperopoulou F, Athanasiou-Metaxa M. J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022 [Abstract] [Full Text] [Related]
6. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor]. Bai CM, Xu GX, Zhao YQ, Han SM, Shan YD. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272 [Abstract] [Full Text] [Related]
7. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load. Torti C, Lapadula G, Barreiro P, Soriano V, Mandalia S, De Silvestri A, Suter F, Maggiolo F, Antinori A, Antonucci F, Maserati R, El Hamad I, Pierotti P, Sighinolfi L, Migliorino G, Ladisa N, Carosi G, Italian MASTER Cohort. J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879 [Abstract] [Full Text] [Related]
15. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia]. Bai CM, Zou XY, Zhao YQ, Han SM, Shan YD, Thrombopoietin Clinical Trail Cooperation Group. Zhonghua Yi Xue Za Zhi; 2004 Mar 02; 84(5):397-400. PubMed ID: 15061993 [Abstract] [Full Text] [Related]
17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR, Swiss HIV Cohort Study. Clin Infect Dis; 2008 Oct 15; 47(8):1093-101. PubMed ID: 18783328 [Abstract] [Full Text] [Related]
18. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP. Acta Paediatr Taiwan; 2006 Oct 15; 47(5):226-31. PubMed ID: 17352309 [Abstract] [Full Text] [Related]